American International Group, Inc. Share Price Target ‘$85.00’, now 7.8% Upside Potential

DirectorsTalk Interviews

American International Group, Inc. with ticker code (AIG) now have 16 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The target price High/Low ranges between $92.00 and $75.00 calculating the average target share price we see $85.00. (at the time of writing). Now with the previous closing price of $78.82 this now indicates there is a potential upside of 7.8%. The day 50 moving average is $77.09 while the 200 day moving average is $68.44. The company has a market cap of 51.98B. The stock price is currently at: $78.32 USD

The potential market cap would be $56,053,923,435 based on the market consensus.

The company has a dividend yield of 0.89%. Other points of data to note are a P/E ratio of 11.71, revenue per share of $68.56 and a 0.82% return on assets.

American International Group, Inc. is a global insurance company. The Company provides a range of property and casualty insurance, life insurance, retirement solutions, and other financial services to customers in over 70 countries and jurisdictions. Its diverse offerings include products and services that help businesses and individuals protect their assets, manage risks and provide for retirement security. It operates through three segments: General Insurance, Life and Retirement, and Other Operations. Its General Insurance segment consists of two segments: North America and International. Its Life and Retirement segment consists of four segments: Individual Retirement, Group Retirement, Life Insurance and Institutional Markets. Its North America and International segments consist of two product categories: Commercial Lines, which consists of Liability, Financial Lines, Property and Global Specialty, and Personal Insurance, which consists of Personal Lines, and Accident and Health.

Share on:

Latest Company News

AIM admission marks new phase for EDX Medical’s diagnostic expansion

EDX Medical has joined AIM as it advances the commercial rollout of diagnostic tests targeting cancer and other major diseases, supported by growing clinical screening programmes.

QinetiQ strengthens maritime test positioning as uncrewed naval systems scale

QinetiQ’s expanded underwater testing capacity strengthens its role in the growing market for uncrewed maritime defence systems.

Zotefoams update strengthens the investment case

Zotefoams’ latest update shows a stronger, broader growth business than the current valuation appears to recognise.

Commercial milestones could define Quadrise’s next investment phase

Commercial agreements, project execution and customer adoption remain the key markers investors are likely to watch as Quadrise moves further towards commercial deployment.

Natural hydrogen opens a new investment front in South Australia

Investor interest in natural hydrogen is building as South Australia becomes an early proving ground for exploration, testing and potential commercial development.

Touchstone advances Trinidad output strategy as new wells support cash flow

Touchstone Exploration has brought two Trinidad oil wells into production while advancing gas infrastructure work aimed at improving cash flow, pricing and operational reliability.

    Search